SEC: Drug distributor must allow shareholder vote on opioid-related clawback disclosure

THE SEC HAS RULED that AmerisourceBergen Drug Corp. must allow shareholders to propose disclosing executive pay clawbacks related to opioid distribution misconduct. /BLOOMBERG FILE PHOTO/DHIRAJ SINGH
THE SEC HAS RULED that AmerisourceBergen Drug Corp. must allow shareholders to propose disclosing executive pay clawbacks related to opioid distribution misconduct. /BLOOMBERG FILE PHOTO/DHIRAJ SINGH
PROVIDENCE— State Treasurer Seth Magaziner and national coalition Investors for Opioid Transparency have won an U.S. Securities and Exchange Commission ruling that AmerisourceBergen Drug Corp. shareholders may propose during an annual meeting that the pharmaceutical distributor disclose “clawed-back” compensation from senior executives due to misconduct contributing to the national opioid crisis, Magaziner announced Monday. Shareholders are…

Want More?

Register or subscribe with
Providence Business News to continue reading.

Register Now

Subscribe for $1

Already registered? Login to access more articles.

*Registered users get access to a limited number of free articles every month.

Purchase NowWant to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.

- Advertisement -